59 related articles for article (PubMed ID: 4202783)
1. The relationship between the O-antigenic lipopolysaccharides and serological specificity in strains of Pseudomonas aeruginosa of different O-serotypes.
Chester IR; Meadow PM; Pitt TL
J Gen Microbiol; 1973 Oct; 78(2):305-18. PubMed ID: 4202783
[No Abstract] [Full Text] [Related]
2. Remodeling of O Antigen in Mucoid Pseudomonas aeruginosa via Transcriptional Repression of
Cross AR; Goldberg JB
mBio; 2019 Feb; 10(1):. PubMed ID: 30782665
[No Abstract] [Full Text] [Related]
3. Culturability and Expression of Outer Membrane Proteins during Carbon, Nitrogen, or Phosphorus Starvation of Pseudomonas fluorescens DF57 and Pseudomonas putida DF14.
Kragelund L; Nybroe O
Appl Environ Microbiol; 1994 Aug; 60(8):2944-8. PubMed ID: 16349359
[TBL] [Abstract][Full Text] [Related]
4. Structural and serological specificities of Pasteurella haemolytica lipopolysaccharides.
Lacroix RP; Duncan JR; Jenkins RP; Leitch RA; Perry JA; Richards JC
Infect Immun; 1993 Jan; 61(1):170-81. PubMed ID: 8418039
[TBL] [Abstract][Full Text] [Related]
5. Characterization of lipopolysaccharide-deficient mutants of Pseudomonas aeruginosa derived from serotypes O3, O5, and O6.
Dasgupta T; de Kievit TR; Masoud H; Altman E; Richards JC; Sadovskaya I; Speert DP; Lam JS
Infect Immun; 1994 Mar; 62(3):809-17. PubMed ID: 8112851
[TBL] [Abstract][Full Text] [Related]
6. Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility.
Legakis NJ; Aliferopoulou M; Papavassiliou J; Papapetropoulou M
J Clin Microbiol; 1982 Sep; 16(3):458-63. PubMed ID: 6813351
[TBL] [Abstract][Full Text] [Related]
7. 31P N.m.r. evidence for the presence of triphosphate residues in lipopolysaccharides from Pseudomonas aeruginosa.
Wilkinson SG
Biochem J; 1981 Dec; 199(3):833-5. PubMed ID: 6803774
[No Abstract] [Full Text] [Related]
8. Chemical and chromatographic analysis of lipopolysaccharide from an antibiotic-supersusceptible mutant of Pseudomonas aeruginosa.
Kropinski AM; Kuzio J; Angus BL; Hancock RE
Antimicrob Agents Chemother; 1982 Feb; 21(2):310-9. PubMed ID: 6803667
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa bacteriophage phi PLS27-lipopolysaccharide interactions.
Jarrell KF; Kropinski AM
J Virol; 1981 Nov; 40(2):411-20. PubMed ID: 6798225
[TBL] [Abstract][Full Text] [Related]
10. Serum sensitivity of a Pseudomonas aeruginosa mucoid strain.
Schiller NL; Alazard MJ; Borowski RS
Infect Immun; 1984 Sep; 45(3):748-55. PubMed ID: 6432698
[TBL] [Abstract][Full Text] [Related]
11. Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa.
Cryz SJ; Pitt TL; Fürer E; Germanier R
Infect Immun; 1984 May; 44(2):508-13. PubMed ID: 6425224
[TBL] [Abstract][Full Text] [Related]
12. 2,3-diamino-2,3-dideoxy-D-glucofuranurono-6,3-lactam from the hydrolysate of Pseudomonas aeruginosa P14 lipopolysaccharide.
Okuda S; Suzuki N
Biochem J; 1983 Dec; 215(3):597-604. PubMed ID: 6419728
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.
Hancock RE; Mutharia LM; Chan L; Darveau RP; Speert DP; Pier GB
Infect Immun; 1983 Oct; 42(1):170-7. PubMed ID: 6413410
[TBL] [Abstract][Full Text] [Related]
14. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains.
Darveau RP; Hancock RE
J Bacteriol; 1983 Aug; 155(2):831-8. PubMed ID: 6409884
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species.
Mutharia LM; Crockford G; Bogard WC; Hancock RE
Infect Immun; 1984 Sep; 45(3):631-6. PubMed ID: 6381310
[TBL] [Abstract][Full Text] [Related]
16. Cross-protection by Pseudomonas aeruginosa polysaccharides.
Pier GB
Infect Immun; 1982 Dec; 38(3):1117-22. PubMed ID: 6185423
[TBL] [Abstract][Full Text] [Related]
17. High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2.
Pier GB; Sidberry HF; Sadoff JC
Infect Immun; 1981 Nov; 34(2):461-8. PubMed ID: 6171520
[TBL] [Abstract][Full Text] [Related]
18. Studies of the polysaccharide fraction from the lipopolysaccharide of Pseudomonas alcaligenes.
Lomax JA; Gray GW; Wilkinson SG
Biochem J; 1974 Jun; 139(3):633-43. PubMed ID: 4369226
[TBL] [Abstract][Full Text] [Related]
19. Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa.
Luzar MA; Montie TC
Infect Immun; 1985 Nov; 50(2):572-6. PubMed ID: 3932213
[TBL] [Abstract][Full Text] [Related]
20. Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides.
Cryz SJ; Meadow PM; Fürer E; Germanier R
Eur J Clin Microbiol; 1985 Apr; 4(2):180-5. PubMed ID: 3924605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
